DMTK DermTech Inc

Price (delayed)

$0.87

Market cap

$29.79M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.51

Enterprise value

$44.27M

DermTech is the leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by its non-invasive skin genomics platform. DermTech's mission is to transform ...

Highlights
DermTech's EPS has increased by 10% from the previous quarter and by 9% YoY
The net income rose by 8% since the previous quarter and by 3.9% year-on-year
The gross margin has plunged by 147% YoY but it has grown by 38% from the previous quarter
DermTech's gross profit has shrunk by 146% YoY but it has increased by 36% QoQ
DermTech's debt has soared by 132% YoY
DermTech's equity has plunged by 53% YoY and by 17% from the previous quarter

Key stats

What are the main financial stats of DMTK
Market
Shares outstanding
34.24M
Market cap
$29.79M
Enterprise value
$44.27M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.4
Price to sales (P/S)
2.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.08
Earnings
Revenue
$14.37M
EBIT
-$110.02M
EBITDA
-$104.04M
Free cash flow
-$88.5M
Per share
EPS
-$3.51
Free cash flow per share
-$2.62
Book value per share
$2.17
Revenue per share
$0.42
TBVPS
$4.08
Balance sheet
Total assets
$137.9M
Total liabilities
$64.83M
Debt
$55.17M
Equity
$73.06M
Working capital
$63.29M
Liquidity
Debt to equity
0.76
Current ratio
6.01
Quick ratio
5.96
Net debt/EBITDA
-0.14
Margins
EBITDA margin
-724.2%
Gross margin
-3.6%
Net margin
-765.8%
Operating margin
-785.6%
Efficiency
Return on assets
-65.3%
Return on equity
-109.8%
Return on invested capital
-71.5%
Return on capital employed
-87.8%
Return on sales
-765.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DMTK stock price

How has the DermTech stock price performed over time
Intraday
-32.03%
1 week
-31.5%
1 month
-29.27%
1 year
-78.88%
YTD
-50.29%
QTD
-50.29%

Financial performance

How have DermTech's revenue and profit performed over time
Revenue
$14.37M
Gross profit
-$520,000
Operating income
-$112.87M
Net income
-$110.02M
Gross margin
-3.6%
Net margin
-765.8%
The gross margin has plunged by 147% YoY but it has grown by 38% from the previous quarter
DermTech's gross profit has shrunk by 146% YoY but it has increased by 36% QoQ
DermTech's operating margin has increased by 10% from the previous quarter
DermTech's net margin has increased by 10% from the previous quarter

Growth

What is DermTech's growth rate over time

Valuation

What is DermTech stock price valuation
P/E
N/A
P/B
0.4
P/S
2.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.08
DermTech's EPS has increased by 10% from the previous quarter and by 9% YoY
The price to book (P/B) is 93% lower than the 5-year quarterly average of 5.5 and 50% lower than the last 4 quarters average of 0.8
DermTech's equity has plunged by 53% YoY and by 17% from the previous quarter
The stock's P/S is 96% below its 5-year quarterly average of 46.3 and 61% below its last 4 quarters average of 5.2
The revenue has increased by 2.4% since the previous quarter but it has declined by 2.2% year-on-year

Efficiency

How efficient is DermTech business performance
The return on equity has dropped by 84% year-on-year and by 11% since the previous quarter
DermTech's return on invested capital has increased by 43% YoY and by 14% QoQ
The company's return on assets fell by 28% YoY
DermTech's ROS has increased by 10% from the previous quarter

Dividends

What is DMTK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DMTK.

Financial health

How did DermTech financials performed over time
The total assets is 113% greater than the total liabilities
DermTech's total liabilities has soared by 66% YoY but it has decreased by 6% from the previous quarter
DermTech's current ratio has decreased by 37% YoY but it has increased by 2.7% QoQ
DermTech's debt is 24% less than its equity
DermTech's debt has soared by 132% YoY
DermTech's equity has plunged by 53% YoY and by 17% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.